|
Market Research Report
|
Discovery on TARGETConcurrent Tracks Seventh Annual Fourth Annual Fourth Annual Concurrent Tracks Pre Conference Strategies for Effective RNAi Screens Targeting GPCRs and Ion Channels with Antibodies Strategies for Optimizing RNAi Delivery Combating Diabetes with Strategies for Enhanced Pancreatic Beta Cell Survival and Regeneration Structure-Based Design of Ion Channels Cardiovascular Safety in Drug Development - From Preclinical to Phase I KEYNOTE PRESENTERS
 David Clapham, M.D., Ph.D.,Howard Hughes Medical Institute  Michael Dabrowski, Ph.D.,AstraZeneca  Gregory J. Kaczorowski,School; Robert Wood Johnson Medical School  John M. Maraganore, Ph.D.,Alnylam Pharmaceuticals, Inc.  Graeme Milligan, Ph.D.,University of Glasgow  Steven E. Nissen, M.D.,M.A.C.C., Cleveland Clinic Foundation David Root, Ph.D., The RNAi Consortium Broad Institute of MIT and Harvard Anja J. Stauber, Ph.D., DABT, Eli Lilly and Company Eric M. Verdin, M.D., University of California, San Francisco |
   
.jpg "AppliedBiosystems")  .jpg "Gloucester Pharma")    .jpg "Biovex-Neurovex"){kind=small} .jpg "PQ")  .jpg "taconic resized 170") |
|
|
||
.jpg "Accuri")
